Munit SA has announced it will be participate as an exhibitor at the 4th Annual Formulation & Drug Delivery Congress, 8 – 9 May 2018 in London.
Over 350 senior level experts will be attending the 2018 event to network about the latest developments & participate in presentations covering the below main areas:
• Large and Small Molecule Formulation and Drug Delivery
• Novel Drug Delivery Devices
• Bioanalysis and Stabilisation
Please come and visit us by our booth where our Business Develop will be delighted to welcome you.

Respiratory Drug Delivery Conference in Tucson, Arizona

The 2018th edition of the RDD Conference (Respiratory Drug Delivery) will be held at the JW Marriott in Tucson, Arizona, from April 22-26, 2018. About 600 participants are expected at this international symposium dedicated to themes surrounding nasal and pulmonary drug delivery. The RDD conference includes Seminars, cutting-edge presentations on new technologies and services related to nasal and pulmonary drug delivery and a technology exhibition. Munit SA will represent its affiliates Jetpharma and Microchem at its exhibition space. We invite all interested visitors to find out more about our services and activities.

DCAT 2018 in New York, US

MUnit is glad to announce its participation in the forthcoming DCAT. The exhibition will take place in New York from 19 to 22 March 2018.
We will be very pleased to tell you more about our activities based on 40 years of experience in the micronisation of APIs and high-potent active pharmaceutical ingredients (HPAPI).
Please come and visit us at the Kimberly Hotel, New York City.
For meeting requests, please contact MUnit.

World HPAPI Congress Basel

We invite you to join us at stand 34 during the World HPAPI Congress , co-located with the European Antibody Congress, World Biosimilar Congress and the World Immunotherapy Congress from October 31st to November 2nd in Basel, Switzerland.

CPhI Worldwide 2017 in Frankfurt, Germany

Munit and its affiliates Jetpharma and Microchem welcome you at the CPhI in Frankfurt. Our technical and commercial staff will be pleased to present you our view on the world of micronization.
Join us in hall 8 J62.

JETPHARMA invests in new equipment

JETPHARMA, micronization partner of MUNIT, has just completed the renewal and enlargement of its QC Lab. New lab areas have been created and new instruments of analysis installed​ ​, this will increase the in house capacity for both internal and external analytical request. This renovation is part of 2017 plan of investments, decided by Martinoli’s Family (private ownership of JETPHARMA) in 2016 together with other technological ​​implementation ​already in progress in other areas and departments. JETPHARMA is a white little pearl among the giants of the pharmaceutical industry, investing part of revenues to valori​ze​ ​its structure, as well as the knowledge and professional training of its employees, to increase safety measures and expertise; this aptitude can only translate in a healthy growth and the determination to remain always on the top level of this sector. The long term​​ and farseeing development plan finds solid base into the tradition of a 30 years old Company, economically independent and aware of its potential and of the place JETPHARMA gained in the leadership, granting its clients and employees continuity, loyalty, certitude, but also change and enhancement.